Though Novavax is behind in the COVID-19 vaccine race, a blockbuster deal with Sanofi and a differentiated product means the ...

The UK has approved its second Covid-19 vaccine for emergency use: AZ/Oxford’s candidate. This is welcome news given how ...

The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...

In light of recent statements by Opposition Leader Kamla Persad-Bissessar and Health Minister Terrence Deyalsingh regarding ...

The potential of mRNA vaccines was established during the COVID-19 pandemic. Now, a new wave of candidates could soon hit the ...

Doses of Moderna's updated COVID-19 vaccine are expected to begin arriving in Canada 'within days,' a spokesperson for the ...

Catching the virus that causes COVID-19 or getting a COVID-19 vaccination gives you protection, also called immunity, from the virus. But over time, that protection seems to ...

Epidemiologists and a federal health agency have criticized new COVID-19 guidance from Florida Surgeon General Joseph Ladapo as “dangerous” and a repeat of “misleading and false statements about COVID ...

The companies reported mixed results in their phase 3 trial of their mRNA vaccine, which includes antigens for influenza A and B, as well as the SARS-CoV-2 virus that causes COVID-19, and have ...

Imperial’s vaccine is the first one to trial saRNA against COVID-19, but other RNA-based vaccines are also in clinical trials for coronavirus, namely Moderna’s mRNA-1273 – already in late ...

In an era of increased strike activity and union power, labour experts say it's not surprising to see more calls for ...